Author

Anirban Maitra

Professor of Translational Molecular Pathology, UT MD Anderson Cancer Center - Cited by 1,10,556 - Pancreatic cancer - genomics - experimental therapeutics

Biography

Dr. Maitra is currently an Associate Professor of Pathology and Oncology, and an affiliate faculty at the McKusick-Nathans Institute of Genetic Medicine. He is the Associate Editor of Current Molecular Medicine and has received numerous awards for his research studies including the Benjamin Castleman Award, the Warren R. Lang Award, the Gordon Vawter Award, the Harry Neustein Award, and the Lotte Strauss Award.
Title
Cited by
Year
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
S Cao, JR Wang, S Ji, P Yang, Y Dai, S Guo, MD Montierth, JP Shen, ...Nature biotechnology 40 (11), 1624-1633, 2022202
19
2022
Pancreatic cancer: Advances and challenges
CJ Halbrook, CA Lyssiotis, MP di Magliano, A MaitraCell 186 (8), 1729-1754, 2023202
10
2023
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
P Gulhati, A Schalck, S Jiang, X Shang, CJ Wu, P Hou, SH Ruiz, LS Soto, ...Nature Cancer 4 (1), 62-0, 2023202
8
2023
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ...Nature Medicine, 1-13, 2023202
5
2023
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
Y Kang, J Deng, J Ling, X Li, YJ Chiang, EJ Koay, H Wang, JK Burks, ...The Journal of Clinical Investigation 132 (24), 2022202
5
2022
PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
JE Douglas, S Liu, J Ma, RA Wolff, S Pant, A Maitra, EP Tamm, P Bhosale, ...BMC cancer 22 (1), 1-12, 2022202
5
2022
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer
Y Zhang, X Chen, H Wang, S Gordon-Mitchell, S Sahu, TD Bhagat, ...Journal of Hematology & Oncology 15 (1), 1-5, 2022202
4
2022
Bacterial culture underestimates lung pathogen detection and infection status in cystic fibrosis
H Gavillet, L Hatfield, D Rivett, A Jones, A Maitra, A Horsley, ...Microbiology Spectrum 10 (5), e0019-22, 2022202
4
2022
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
AJ Sohn, M Taherian, MHG Katz, LR Prakash, D Chatterjee, H Wang, ...The American Journal of Surgical Pathology 47 (4), 41-430, 030
2
2023
Oncogenic KrasG12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with …
Oncogenic KrasG1D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with …KK Mahadevan, K McAndrews, V LeBleu, S Yang, H Lyu, B Li, ...bioRxiv, 03.0. 15.58757, 030
2
2023
Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach
W Chen, RK Butler, E Lustigova, ST Chari, A Maitra, JA Rinaudo, BU WuJournal of Clinical Gastroenterology 57 (1), 103-110, 030
2
2023
1
2023
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention
SD Haldar, E Vilar, A Maitra, N ZaidiCancer Prevention Research, OF-OF3, 2023202
1
2023